NCT05834621View on ClinicalTrials.gov

AMNIOmics: A Prenatal Rapid Genome Validation Study

WithdrawnOBSERVATIONAL
0
Timeline

Start Date

January 7, 2025

Primary Completion Date

January 7, 2025

Study Completion Date

January 7, 2025

Conditions
Multiple Anomalies of FetusGenetic Predisposition SuspectedAmniocentesis Affecting Fetus or NewbornFamily Members
Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT05834621 - AMNIOmics: A Prenatal Rapid Genome Validation Study | Biotech Hunter | Biotech Hunter